Mary Weger - 01 Dec 2022 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Role
Chief People Officer
Signature
/s/ Todd Girolamo, attorney in fact
Issuer symbol
PROK
Transactions as of
01 Dec 2022
Net transactions value
$0
Form type
4
Filing time
06 Jan 2023, 15:59:34 UTC
Next filing
18 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PROK Employee stock option (right to buy) Award $0 +450,000 $0.000000 450,000 01 Dec 2022 Class A Ordinary Shares 450,000 $10.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The right to purchase common stock vests over four years as follows: 25% on December 1, 2023 and the remaining 75% in substantially equal monthly installments over a 36 month period beginning on December 1, 2023.